May 7 (Reuters) - Vanda Pharmaceuticals Inc ( VNDA ):
* VANDA PHARMACEUTICALS CONFIRMS RECEIPT OF REVISED
UNSOLICITED
TAKEOVER PROPOSAL FROM FUTURE PAK
* VANDA PHARMACEUTICALS INC ( VNDA ) - REVISED PROPOSAL CONSISTS OF A
$7.25
TO $7.75 PER SHARE IN CASH PLUS CERTAIN CONTINGENT VALUE RIGHTS
* VANDA PHARMACEUTICALS INC ( VNDA ) - DOES NOT INTEND TO COMMENT
FURTHER
ON REVISED, UNSOLICITED PROPOSAL BEFORE BOARD HAS COMPLETED ITS
REVIEW
Source text for Eikon:
Further company coverage: